Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2024 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2024 Earnings Call Transcript August 8, 2024

Ginkgo Bioworks Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.10568 EPS, expectations were $-0.08.

Megan LeDuc: Good evening. I’m Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks as always for joining us. We’re looking forward to updating you on our progress. As a reminder, during the...